Clinical trial
Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental
NCT00404833 · Hospital Authority, Hong Kong, Other · Completed
Key facts
| NCT number | NCT00404833 |
|---|---|
| Title | Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental |
| Official title | A Prospective Randomized Open-label Study to Compare Mycophenolate Mofetil and Corticosteroid With Conventional Immunosuppressive Treatment on Proteinuria in Idiopathic Membranous Nephropathy (MN) and Focal Segmental Glomerulosclerosis (FSGS) |
| Lead sponsor | Hospital Authority, Hong Kong, Other |
| Collaborators | The University of Hong Kong |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Glomerulonephritis, Membranous, Glomerulosclerosis, Focal |
| Intervention type | Drug |
| Interventions | prednisolone and mycophenolate mofetil, prednisolone and chlorambucil |
| Enrollment | 16 |
| Start date | Jan 1, 2003 |
| Completion | Dec 1, 2006 |
| First posted | Nov 29, 2006 |
| Last update posted | Oct 23, 2013 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: